We've found
33,560
archived clinical trials in
Neurology
We've found
33,560
archived clinical trials in
Neurology
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures
Updated: 12/31/1969
An Open-Label, Multicenter Study With an Extension Phase to Evaluate the Safety, Tolerability, and Exposure-Efficacy Relationship of Perampanel Oral Suspension When Administered as an Adjunctive Therapy in Pediatric Subjects (Age 4 to Less Than 12 Years) With Inadequately Controlled Partial-Onset Seizures or Primary Generalized Tonic Clonic Seizures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Updated: 12/31/1969
An Open-label Safety and Efficacy Study of VY-AADC01 Administered by MRI-Guided Convective Infusion Using a Posterior Trajectory Into the Putamen of Participants With Parkinson's Disease With Fluctuating Responses to Levodopa
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Updated: 12/31/1969
Validation of Brain Function Assessment Algorithm for mTBI From Injury to Rehabilitation in College Athletes
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Updated: 12/31/1969
Health System Integration of Tools to Improve Primary Care for Autistic Adults
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Incredible Years Program for Parents of Children With Autism
Updated: 12/31/1969
Evaluation of Incredible Years Parenting Program for Caregivers of Children With Autism
Status: Enrolling
Updated: 12/31/1969
Incredible Years Program for Parents of Children With Autism
Updated: 12/31/1969
Evaluation of Incredible Years Parenting Program for Caregivers of Children With Autism
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children
Updated: 12/31/1969
Traumatic Injury Clinical Trial Evaluating Tranexamic Acid in Children (TIC-TOC): A Pilot and Feasibility Study
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Chart Review: Central Motor Conduction Time in Neurological Disorders
Updated: 12/31/1969
Chart Review: Central Motor Conduction Time in Neurological Disorders
Status: Enrolling
Updated: 12/31/1969
Chart Review: Central Motor Conduction Time in Neurological Disorders
Updated: 12/31/1969
Chart Review: Central Motor Conduction Time in Neurological Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Updated: 12/31/1969
A Study to Monitor the Use of an Amino Acid-Based Infant Formula
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials